Pierrel is a global provider specializing in the production, development, registration, and licensing of dental anesthetics and medical devices for oral care. With over 70 years of experience, Pierrel is one of the leading manufacturers of dental anesthetics worldwide. Their flagship product, Orabloc, has achieved significant market share in the United States and is sold in most global markets.

Pierrel is authorized by the EMA (European Medicines Agency) and FDA (Food and Drug Administration) for aseptic production of injectable drugs. In addition to anesthetics, they also offer complementary medical devices for dental injections and oral health screening. As an Italian pharmaceutical company established in 1948, Pierrel combines quality and innovation to serve the oral care sector.

They are listed on Euronext Milan and have a strong focus on product development and market presence. For dentists, distributors, and investors interested in the latest financial news and updates, Pierrel provides comprehensive investor relations information